Christopher Lanigan

804 total citations
27 papers, 541 citations indexed

About

Christopher Lanigan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Christopher Lanigan has authored 27 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Christopher Lanigan's work include HER2/EGFR in Cancer Research (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Lung Cancer Research Studies (6 papers). Christopher Lanigan is often cited by papers focused on HER2/EGFR in Cancer Research (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Lung Cancer Research Studies (6 papers). Christopher Lanigan collaborates with scholars based in United States, Azerbaijan and Australia. Christopher Lanigan's co-authors include Carol Farver, Sanjay Mukhopadhyay, Raymond R. Tubbs, Josephine K. Dermawan, Eugen C. Minca, C. Patrick, Bryce P. Portier, Nathan A. Pennell, Yan Feng and Daniela Allende and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Christopher Lanigan

26 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Lanigan United States 12 322 218 138 111 104 27 541
Natalyn Hawk United States 9 432 1.3× 175 0.8× 164 1.2× 118 1.1× 45 0.4× 25 573
Shozo Mori Japan 11 288 0.9× 201 0.9× 138 1.0× 69 0.6× 241 2.3× 63 688
Gregory Gagnon United States 11 183 0.6× 218 1.0× 86 0.6× 78 0.7× 70 0.7× 17 561
Peter Lim Canada 16 316 1.0× 145 0.7× 317 2.3× 138 1.2× 108 1.0× 32 1.5k
Yulia Strenov Israel 13 194 0.6× 74 0.3× 92 0.7× 127 1.1× 113 1.1× 19 622
Emmanuelle Samalin France 16 562 1.7× 353 1.6× 111 0.8× 114 1.0× 78 0.8× 75 827
Fengchun Zhang China 14 262 0.8× 218 1.0× 77 0.6× 35 0.3× 65 0.6× 29 769
Maria Scardoni Italy 15 422 1.3× 136 0.6× 266 1.9× 126 1.1× 253 2.4× 21 824
Jennifer A. Dorth United States 15 371 1.2× 272 1.2× 61 0.4× 76 0.7× 115 1.1× 60 837
Sunil Babu United States 16 581 1.8× 304 1.4× 65 0.5× 83 0.7× 104 1.0× 38 1.2k

Countries citing papers authored by Christopher Lanigan

Since Specialization
Citations

This map shows the geographic impact of Christopher Lanigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Lanigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Lanigan more than expected).

Fields of papers citing papers by Christopher Lanigan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Lanigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Lanigan. The network helps show where Christopher Lanigan may publish in the future.

Co-authorship network of co-authors of Christopher Lanigan

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Lanigan. A scholar is included among the top collaborators of Christopher Lanigan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Lanigan. Christopher Lanigan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ababneh, Emad, et al.. (2022). Evaluation of Lineage/Site-specific Nuclear Immunohistochemical Markers SATB2, Cyclin D1, SALL4, and BCOR in High-grade Endometrial Carcinomas. International Journal of Gynecological Pathology. 42(5). 443–450. 1 indexed citations
2.
Bayık, Defne, Adam Lauko, Gustavo Roversi, et al.. (2020). Hepatobiliary malignancies have distinct peripheral myeloid-derived suppressor cell signatures and tumor myeloid cell profiles. Scientific Reports. 10(1). 18848–18848. 18 indexed citations
3.
Calhoun, Benjamin C., et al.. (2018). Analytical and clinical performance of progesterone receptor antibodies in breast cancer. Annals of Diagnostic Pathology. 35. 21–26. 3 indexed citations
4.
Mukhopadhyay, Sanjay, Josephine K. Dermawan, Christopher Lanigan, & Carol Farver. (2018). Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections. Modern Pathology. 32(1). 100–109. 97 indexed citations
5.
Cheah, Alison L., Christopher Lanigan, Steven D. Billings, et al.. (2018). ALK Expression in Angiomatoid Fibrous Histiocytoma. The American Journal of Surgical Pathology. 43(1). 93–101. 43 indexed citations
6.
7.
8.
Banks, Peter M., Angela M. B. Collie, Christopher Lanigan, et al.. (2015). Dual expression of MYC and BCL2 proteins predicts worse outcomes in diffuse large B-cell lymphoma. Leukemia & lymphoma. 57(7). 1640–1648. 12 indexed citations
9.
Lanigan, Christopher, et al.. (2015). Immunohistochemistry forBRAFV600E in the Differential Diagnosis of Hairy Cell Leukemia vs Other Splenic B-Cell Lymphomas. American Journal of Clinical Pathology. 144(1). 87–93. 9 indexed citations
10.
Minca, Eugen C., Hongwei Wang, Zhen Wang, et al.. (2014). Detection of immunoglobulin light‐chain restriction in cutaneous B‐cell lymphomas by ultrasensitive bright‐field mRNA in situ hybridization. Journal of Cutaneous Pathology. 42(2). 82–89. 7 indexed citations
11.
Minca, Eugen C., Christopher Lanigan, Jordan Reynolds, et al.. (2014). ALK Status Testing in Non–Small-Cell Lung Carcinoma by FISH on ThinPrep Slides with Cytology Material. Journal of Thoracic Oncology. 9(4). 464–468. 44 indexed citations
12.
Minca, Eugen C., Raymond R. Tubbs, Bryce P. Portier, et al.. (2014). Genomic microarray analysis on formalin-fixed paraffin-embedded material for uveal melanoma prognostication. Cancer Genetics. 207(7-8). 306–315. 5 indexed citations
13.
Feng, Yan, Eugen C. Minca, Christopher Lanigan, et al.. (2014). High MET Receptor Expression But Not Gene Amplification in ALK 2p23 Rearrangement Positive Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 9(5). 646–653. 28 indexed citations
14.
Feng, Yan, Arun D. Singh, Christopher Lanigan, Raymond R. Tubbs, & C. Patrick. (2013). Choroidal Metastases Responsive to Crizotinib Therapy in a Lung Adenocarcinoma Patient with ALK 2p23 Fusion Identified by ALK Immunohistochemistry. Journal of Thoracic Oncology. 8(12). e109–e111. 8 indexed citations
15.
Minca, Eugen C., Bryce P. Portier, Zhen Wang, et al.. (2013). ALK Status Testing in Non–Small Cell Lung Carcinoma. Journal of Molecular Diagnostics. 15(3). 341–346. 91 indexed citations
16.
Lanigan, Christopher, et al.. (2013). Immunoarchitectural Patterns of Germinal Center Antigens Including LMO2 Assist in the Differential Diagnosis of Marginal Zone Lymphoma vs Follicular Lymphoma. American Journal of Clinical Pathology. 140(2). 149–154. 7 indexed citations
17.
Tubbs, Raymond R., Hongwei Wang, Zhen Wang, et al.. (2013). Ultrasensitive RNA In Situ Hybridization for Detection of Restricted Clonal Expression of Low-Abundance Immunoglobulin Light Chain mRNA in B-Cell Lymphoproliferative Disorders. American Journal of Clinical Pathology. 140(5). 736–746. 25 indexed citations
18.
Minca, Eugen C., et al.. (2013). Abstract P1-02-04: Array based resolution of HER2 amplification status in breast carcinomas displaying apparent chromosome 17 aneusomy. Cancer Research. 73(24_Supplement). P1–2. 1 indexed citations
19.
Portier, Bryce P., Eugen C. Minca, Zhen Wang, et al.. (2013). HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma. Oncotarget. 4(10). 1662–1672. 20 indexed citations
20.
Rogerson, Mary, P B Rylance, Catarina Sousa, et al.. (1989). Carnitine and Weakness in Haemodialysis Patients. Nephrology Dialysis Transplantation. 4(5). 366–371. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natalyn Hawk Breakdown of academic impact, for papers by Shozo Mori Breakdown of academic impact, for papers by Gregory Gagnon Breakdown of academic impact, for papers by Peter Lim Breakdown of academic impact, for papers by Yulia Strenov Breakdown of academic impact, for papers by Emmanuelle Samalin Breakdown of academic impact, for papers by Fengchun Zhang Breakdown of academic impact, for papers by Maria Scardoni Breakdown of academic impact, for papers by Jennifer A. Dorth Breakdown of academic impact, for papers by Sunil Babu
Rankless by CCL
2026